Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
r-hLIF for Recurrent Implantation Failure in IVF
NCT00504530Phase 2Completed
- Sponsor
- Merck KGaA
- Start
- Sep 2001
- Modality
- Hormones & Growth Factors
01
Overview
A Phase 2 trial of emfilermin in infertility, Recurrent Implantation Failure (RIF), sponsored by Merck KGaA. Started Sep 2001; status: completed.
02
Drugs
emfilermin
03
Conditions
infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT00504530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504530.